116 related articles for article (PubMed ID: 7918738)
1. Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
O'Neil JP; Carlson KE; Anderson CJ; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 1994; 5(3):182-93. PubMed ID: 7918738
[TBL] [Abstract][Full Text] [Related]
2. Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.
DiZio JP; Anderson CJ; Davison A; Ehrhardt GJ; Carlson KE; Welch MJ; Katzenellenbogen JA
J Nucl Med; 1992 Apr; 33(4):558-69. PubMed ID: 1552341
[TBL] [Abstract][Full Text] [Related]
3. Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.
DiZio JP; Fiaschi R; Davison A; Jones AG; Katzenellenbogen JA
Bioconjug Chem; 1991; 2(5):353-66. PubMed ID: 1790176
[TBL] [Abstract][Full Text] [Related]
4. Monooxorhenium(V) complexes with 222-N
Demoin DW; Dame AN; Minard WD; Gallazzi F; Seickman GL; Rold TL; Bernskoetter N; Fassbender ME; Hoffman TJ; Deakyne CA; Jurisson SS
Nucl Med Biol; 2016 Dec; 43(12):802-811. PubMed ID: 27694058
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
6. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor.
Wüst F; Skaddan MB; Leibnitz P; Spies H; Katzenellenbogen JA; Johannsen B
Bioorg Med Chem; 1999 Sep; 7(9):1827-35. PubMed ID: 10530930
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.
Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275
[TBL] [Abstract][Full Text] [Related]
10. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates.
Riddoch RW; Schaffer P; Valliant JF
Bioconjug Chem; 2006; 17(1):226-35. PubMed ID: 16417273
[TBL] [Abstract][Full Text] [Related]
11. New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Janssen AG; van Royen EA
Nucl Med Biol; 1998 Nov; 25(8):791-8. PubMed ID: 9863568
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
[TBL] [Abstract][Full Text] [Related]
13. 7alpha- and 17alpha-substituted estrogens containing tridentate tricarbonyl rhenium/technetium complexes: synthesis of estrogen receptor imaging agents and evaluation using microPET with technetium-94m.
Luyt LG; Bigott HM; Welch MJ; Katzenellenbogen JA
Bioorg Med Chem; 2003 Nov; 11(23):4977-89. PubMed ID: 14604660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.
Kochanny MJ; VanBrocklin HF; Kym PR; Carlson KE; O'Neil JP; Bonasera TA; Welch MJ; Katzenellenbogen JA
J Med Chem; 1993 Apr; 36(9):1120-7. PubMed ID: 8487253
[TBL] [Abstract][Full Text] [Related]
16. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
17. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
18. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-labeled medium-chain fatty acid analogues metabolized by beta-oxidation: radiopharmaceutical for assessing liver function.
Yamamura N; Magata Y; Arano Y; Kawaguchi T; Ogawa K; Konishi J; Saji H
Bioconjug Chem; 1999; 10(3):489-95. PubMed ID: 10346882
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.
Dezutter NA; Dom RJ; de Groot TJ; Bormans GM; Verbruggen AM
Eur J Nucl Med; 1999 Nov; 26(11):1392-9. PubMed ID: 10552079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
